Skip to content

Comparison of the effects of sevoflurane and remimazolam anesthesia on regional cerebral oxygen saturation and optic nerve sheath diameter in patients undergoing laparoscopic gynecological surgery

Comparison of the effects of sevoflurane and remimazolam anesthesia on regional cerebral oxygen saturation and optic nerve sheath diameter in patients undergoing laparoscopic gynecological surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006900
Enrollment
62
Registered
2022-01-06
Start date
2022-05-12
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The method of induction and maintenance of anesthesia according to each group is as follows. - Sevoflurane group: Anesthesia induction is performed with propofol 1.5-2.0 mg/kg, remifentanil 0.5

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients aged 20 – 65 years scheduled for laparoscopic gynecological surgery

Exclusion criteria

Exclusion criteria: Those with cardiovascular disease, those with high blood pressure whose blood pressure is not controlled below the normal range (140/90mmHg) despite taking medications, those with diabetes whose blood sugar is not controlled below 200 mg/dl even after taking medications, and active lung disease Those with cerebral palsy, those with brain tumors and cerebrovascular abnormalities (cerebral aneurysm, arteriovenous malformation), those with infectious eye disease, glaucoma, and ophthalmic surgery, those with a BMI of 30 or higher

Design outcomes

Primary

MeasureTime frame
optic nerve sheath diameter

Secondary

MeasureTime frame
regional cerebral oxymetry

Countries

Korea, Republic of

Contacts

Public ContactChungon Park

Gachon University Gil Medical Center

chungony@gilhospital.com+82-32-460-3400

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026